Led by SK Hynix’s $9bn asset transaction with Intel, China’s technology industry saw a rise of 7.41% in overall cross border deal activity during Q4 2020, when compared with the last four-quarter average, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 58 cross border deals worth $12.12bn were announced in Q4 2020, compared with the last four-quarter average of 54 deals.
venture financing was the leading category in the quarter with 39 cross border deals which accounted for 67.2% of all deals.
In second place was M&A with 15 deals, followed by private equity with four transactions, respectively accounting for 25.8% and 6.9% of overall cross border deal activity in the China’s technology industry during the quarter.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
In terms of value of cross border deals, M&A was the leading deal category in China’s technology industry with total deals worth $9.37bn, while venture financing and private equity deals totalled $2.5bn and $249.04m respectively.
China technology industry cross border deals in Q4 2020: Top deals
The top five technology industry cross border deals accounted for 84.4% of the overall value during Q4 2020.
The combined value of the top five technology cross border deals stood at $10.23bn, against the overall value of $12.12bn recorded for the quarter.
The top five technology industry cross border deals of Q4 2020 tracked by GlobalData were:
1) SK Hynix’s $9bn asset transaction with Intel
2) The $500m venture financing of Hangzhou Lianke Meixun Biomedical Technology by GL Ventures, Hillhouse Capital Group, Tencent Holdings and TrustBridge Partners
3) China Structural Reform Fund, Eastern Bell Capital, Genesis Capital China, GLP-C&D Equity Investment Fund, Legend Capital, Matrix Partners China, Shenzhen Cowincapital, Tencent Holdings, Tiger Management, Xiamen C&D and Yunfeng Capital’s $315m venture financing of ZKH Industrial Supply
4) The $210m venture financing deal with Zhejiang Yiqi Education Technology by Bojia Capital, China Fortune Financial Group, Chuangzhi Capital, Fortune Caizhi, Guangzhou Yingrui Capital Management, SAIF Partners China and The Rise Fund
5) GIC and Warburg Pincus’ venture financing with Gaosi Education Group for $200m.